Our study demonstrated that miR-124 acts as a tumor suppressor by directly targeting FLOT1 in breast cancer, which suggested that miR-124 has potential diagnostic and therapeutic value for breast cancer treatment. This evidence concerns the gene FLOT1 and breast cancer.